Stay updated on Safety of Pegcetacoplan as Add-On in PNH Clinical Trial
Sign up to get notified when there's something new on the Safety of Pegcetacoplan as Add-On in PNH Clinical Trial page.

Latest updates to the Safety of Pegcetacoplan as Add-On in PNH Clinical Trial page
- Check2 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the pegcetacoplan Phase I study, including its study details, eligibility criteria, locations, and results measures, instead of a 403 error.SummaryDifference54%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision identifier was updated from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site footer revision label was updated from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous content and navigation. This blocks access to the study record details, eligibility criteria, locations, and contact information that users rely on to learn about and potentially participate in the study.SummaryDifference19%

Stay in the know with updates to Safety of Pegcetacoplan as Add-On in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pegcetacoplan as Add-On in PNH Clinical Trial page.